Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Quote

Commitment (own venture)

“End of P2b meeting with FDA anticipated in Q1 2026 ... Phase 2 data for R-MDMA (EMP-01) in SAD anticipated in Q1 2026”
· atai Life Sciences: The Leader in Psychedelic Therapeutics (Christian's Substack) · own post

BPL-003 end-of-Phase-2b FDA meeting and EMP-01 social-anxiety Phase 2 data both by end of March 2026.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.